BIVV009-04 (CADENZA) (FL)

BIVV009-04 (CADENZA) (FL)

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Sutimlimab in Patients With Primary Cold Agglutinin Disease Without a Recent History of Blood Transfusion (CADENZA study)


Treatment


Inclusion criteria


Exclusion criteria


Participating sites

Link